Heather Holdermann
Podiatrist · Medford, ORNPI 1013935360
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.3%), education and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Steelhead Surgical Inc at 35.7% of the total. Reporting peaked in 2021 at $1,399 and has fallen 68.3% since, to $444 in 2025.
Across 119 payments — averaging $35.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Steelhead Surgical Inc$1K
- Smith+Nephew$575
- Arthrex$538
- Organogenesis Inc.$521
- Tactile Systems Technology Inc$231
- KCI USA, Inc.$91
- plus $724 from 20 others
What the payments were for
- Travel & lodging$2907%
- Food & beverage$2,22553%
- Education$1,65640%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Steelhead Surgical Inc | 3 | $1,490 |
| Smith+Nephew | 39 | $575 |
| Arthrex | 3 | $538 |
| Organogenesis Inc. | 20 | $521 |
| Tactile Systems Technology Inc | 13 | $231 |
| KCI USA, Inc. | 4 | $91 |
| Stryker(2 entities) | 4 | $85 |
| Treace Medical Concepts, Inc. | 4 | $75 |
| Bioventus LLC | 4 | $73 |
| Biowound Solutions, Inc. | 4 | $62 |
| Solventum Corporation | 2 | $52 |
| Paragon 28, Inc. | 1 | $44 |
| DJO, LLC | 2 | $40 |
| Kerecis Limited | 2 | $39 |
| Alfasigma USA, Inc. | 1 | $34 |
| Orthofix Medical, Inc. | 2 | $31 |
| Merck | 2 | $29 |
| Bone Support Inc. | 1 | $25 |
| Trevena, Inc. | 1 | $23 |
| Acera Surgical, Inc. | 1 | $20 |
| Medela LLC | 1 | $19 |
| Medline Industries LP | 1 | $18 |
| Wildwood Medical LLC | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Amgen | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $12 |
How this compares
$4,172 in reported general payments places this provider in the 75th percentile of 74 podiatrist providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 27 | $726 |
| Meloxicam | 18 | $152 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Medford
- Rick McClureMedford$133K
- James HoldermannMedford$5K
- Jeffery ZimmerMedford$2K
- Michael DekorteMedford$2K
- Cyaandi DoveGrand Ronde$51K
- Stephen SchroederTigard$28K
- Colin MizuoHillsboro$18K
- Melinda NicholesPortland$15K
- Amanda KameryEugene$9K
- Peter PhamBeaverton$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.